Sequential osteoporosis treatment—the order of things

被引:2
作者
Bo Abrahamsen
机构
[1] Holbæk Hospital,Department of Medicine
关键词
D O I
10.1038/nrendo.2015.134
中图分类号
学科分类号
摘要
A recent study shows that preceding teriparatide treatment with 2 years of denosumab treatment leads to lower BMD after 4 years than either administering these interventions in the opposite order or combining them initially. However, BMD measurements could be biased in favour of using teriparatide first, owing to the time required for completion of secondary mineralization.
引用
收藏
页码:570 / 572
页数:2
相关论文
共 11 条
[1]  
Zebaze R(2015)Cortical bone: a challenging geography J. Bone Miner. Res. 30 24-29
[2]  
Seeman E(2008)Effects of treatment with fluoride on bone mineral density and fracture risk—a meta-analysis Osteoporos. Int. 19 257-268
[3]  
Vestergaard P(2008)Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment J. Bone Miner. Res. 23 1591-1600
[4]  
Jorgensen NR(2011)Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis J. Bone Miner. Res. 26 503-511
[5]  
Schwarz P(2010)Placebo-controlled trials in osteoporosis—proceeding with caution N. Engl. J. Med. 363 1365-1367
[6]  
Mosekilde L(2015)Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study J. Bone Miner. Res. 30 39-45
[7]  
Obermayer-Pietsch BM(undefined)undefined undefined undefined undefined-undefined
[8]  
Cosman F(undefined)undefined undefined undefined undefined-undefined
[9]  
Rosen CJ(undefined)undefined undefined undefined undefined-undefined
[10]  
Khosla S(undefined)undefined undefined undefined undefined-undefined